<p><strong>CSL</strong> is interested in research in the broader area of <strong>autoimmunity</strong>, with a focus on <strong>autoantibody, complement and T cell&#x2011;mediated diseases</strong>. The focus of this search is on <strong>removing or downmodulating the autoimmune component causing disease, while simultaneously preserving protective immunity</strong>.</p> <h3><strong>Approaches of Particular Interest</strong></h3> <ul> <li>Antibody&#x2011;based Therapeutics</li> <li>Bi&#x2011;specific (T-cell engaging) Approaches</li> <li>Antibody&#x2011;Drug Conjugates </li> <li>Biologics</li> <li>Tolerance Induction</li> <li>Cell and Gene Therapies</li> </ul> <h3><strong>Development Stage</strong></h3> <ul> <li>Opportunities at the levels of basic through to late pre&#x2011;clinical...</li></ul>

CSL is interested in research in the broader area of autoimmunity, with a focus on autoantibody, complement and T cell‑mediated diseases. 

Seeking Research in B cell and Plasma Cell Depletion Programs

Approaches of Particular Interest

Development Stage

Opportunity types being sought:

To see the full details and submit your response please register now.

Benefits of registration:

Opportunity types being sought: